期刊文献+

血小板交叉配型在免疫性输注无效患者中的临床应用 被引量:18

Clinical application of platelet crossmatch in immune platelet refractoriness
原文传递
导出
摘要 目的探讨血液病患者产生血小板抗体的影响因素及血小板抗体阳性患者经血小板交叉配型后的输注效果。方法用全自动血型仪,采用固相抗体检测法进行血小板抗体筛选及交叉配型,对血小板输注有效率进行统计学分析。结果血小板相关抗体的产生与妊娠史、输血史相关,对产生抗体的患者进行血小板交叉配型后,24h CCI>4.5者为86.7%。结论对于血小板抗体阳性的患者,在保证同型输注的基础上进行血小板交叉配型可以极大的提高血小板输注效率,减少血小板输注无效症的发生。 Objective To investigate the influential factors for the appearance of platelet antibody in hematological patients and to analyze the effect of matched platelet by crossmatch. Methods The antibodies in the platelet of patients were screened. The positive ones were selected to perform the platelet crossmatch using a solid-phase antibody detection system in an automatic machine. Results The production of platelet antibodies is related to the history of pregnancy and blood transfusion. After platelet crossmatch,86. 7% of the patients had 24 h CCI 〉 4. 5. Conclusion Crossmatch of platelet can greatly improve the efficiency of platelet transfusion.
出处 《中国输血杂志》 CAS 北大核心 2016年第7期711-712,共2页 Chinese Journal of Blood Transfusion
关键词 血小板抗体 交叉配型 血小板输注无效 临床应用 platelet antibodies crossmatch platelet refractoriness clinical application
  • 相关文献

参考文献6

二级参考文献45

  • 1尤建国,李玉峰,汪承亚.血小板输注无效及干预措施的研究进展[J].国际输血及血液学杂志,2006,29(6):499-502. 被引量:28
  • 2DzikS.血小板输注支持无效患者的处理.国际输血及血液学杂志,2008,31(1):91-93.
  • 3刘景汉,周俊.血小板输血//刘景汉,兰炯采主编.临床输血学.北京:人民卫生出版社,2011:30-37.
  • 4Panzer S, Eichelberger B, Koren D, et al. Monitoring survival and function of transfused platelets in Bernard-Soulier syndrome by flow cytometry and a cone and plate ( let) analyzer (Impact-R) [J] ' Transfusion ,2007,47 ( I ) : 103-106,.
  • 5British Committee for Standards in Haematology , Blood Transfusion Task Force. Guidelines for the use of platelet transfusions [J] . Br J Haematol,2003 ,122( I) : 10-23.
  • 6Metcalfe P. Platelet antigens and antibody detection [J] . Vox Sanguinis ,2004 ,87 (Suppl I ) : S82-S86.
  • 7Heuer L, Blumenberg D. Management of bleeding in a multi transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of cross-matched platelets [J]. Blood Coagul Fibrinolysis, 2005,16(4) :287-290,.
  • 8Slichter SJ, Davis K, Enright H, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients [J]. Blood, 2005,105(10) :41064114.
  • 9Schiffer CA, Anderson KC, Bennett CL, et at. Platelet transfusion for patients with cancer: clinical practice guidelines of the Ameri- can Society of Clinical Oncology [J] . J Clin Oncol, 200 1 ,19 ( 5) : 1519-1538.
  • 10Geiger TL, Woodard P, Tong X, et al. Human leucocyte antigen alloimmunization after bone marrow transplantation: an association with chronic myelogenous leukaemia [J], Br J Haematol, 2002 , 117(3) :634-641.

共引文献84

同被引文献123

引证文献18

二级引证文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部